Subgroup analyses
DISEASE
The primary outcome will be compared between treatment groups in pre-specified subgroup analyses: age, gender, pre-PCI TIMI flow (0/1 vs 2/3), culprit in left main (LM)/left anterior descending artery (LAD) vs none-LM/LAD, duration of symptom onset to first wire, time from study medicine intervention to first wire, time from first medical contact to first wire, one-vessel disease and multivessel disease, PCI vs CABG, and PCI only. These subgroups will be analyzed using interaction tests. The pre-specified subgroups are factors that are known to influence the clinical course in patients with STEMI.